全膝关节置换术中静脉与局部应用氨甲环酸:640例随机临床试验显示两者均有效
这项多中心随机临床试验纳入640例因骨关节炎行初次单侧全膝关节置换的患者,比较静脉与局部应用氨甲环酸的效果。局部组 calculated blood loss 和引流量均显著高于静脉组,输血率单因素分析无显著差异,但多因素logistic回归中局部组输血可能性为静脉组的2.2倍;两组血栓事件率无显著差异。
要点
- 局部氨甲环酸组 calculated blood loss 均值324 mL,显著高于静脉组271 mL(p=0.005)。
- 局部组引流量均值560 mL,显著高于静脉组456 mL(p<0.0001)。
- 输血率局部组1.6% vs 静脉组0.6%,单因素分析无显著差异(p=0.45),多因素回归中局部组输血可能性为2.2倍(p<0.0001)。
核心结论
- 在这项大型随机临床试验中,静脉与局部应用氨甲环酸均与低输血率相关。
- 静脉氨甲环酸与更少的 calculated blood loss、更低的引流量和更少的输血相关,但组间小差异可能无临床重要性。
- 鉴于血栓并发症发生率低,无法明确确定一种制剂相对另一种的安全性。
研究设计与样本
- 多中心随机临床试验,纳入640例因骨关节炎行初次单侧全膝关节置换的患者,来自2个大型学术中心。
- 患者随机接受静脉氨甲环酸(止血带充气前1 g,关闭切口时1 g)或局部氨甲环酸(3 g稀释于45 mL生理盐水,总容量75 mL,骨水泥固定后局部应用)。
- 两组年龄、性别、体重指数、美国麻醉医师学会(ASA)评分和术前血红蛋白水平相似。
- 进行单因素分析、多元线性回归和多元logistic回归分析。
主要发现
- 局部氨甲环酸组 calculated blood loss 均值324 mL,静脉组271 mL,局部组显著更高(p=0.005)。
- 局部组引流量均值560 mL,静脉组456 mL,局部组显著更高(p<0.0001)。
- 输血率局部组1.6%,静脉组0.6%,单因素分析无显著差异(p=0.45);多元logistic回归分析中,局部组接受输血的可能性为静脉组的2.2倍(p<0.0001)。
- 血栓事件率局部组0.6%,静脉组1.6%,两组无显著差异(p=0.45)。
关键数值与推荐
- 静脉氨甲环酸方案:止血带充气前1 g,关闭切口时1 g。
- 局部氨甲环酸方案:3 g稀释于45 mL生理盐水(总容量75 mL),骨水泥固定后局部应用。
- 证据等级:治疗性I级。
局限性
- 鉴于血栓并发症发生率低,无法明确确定一种氨甲环酸制剂相对另一种的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) reduces bleeding and the need for transfusion after total knee arthroplasty. Most literature has focused on intravenous (IV) administration of TXA, with less data available on the efficacy of topically administered TXA. This multicenter randomized clinical trial specifically assessed the efficacy of topical TXA compared with IV TXA as measured by calculated blood loss, drain output, and transfusion rates. Complications, including venous thromboembolism (VTE), were reported. METHODS: A total of 640 patients who underwent primary unilateral total knee arthroplasty for osteoarthritis at 2 large academic centers were randomized to receive 1 g of IV TXA prior to tourniquet inflation and 1 g at closure, or 3 g of TXA diluted in 45 mL of normal saline solution (total volume of 75 mL) and topically applied after cementation. Age, sex, body mass index, American Society of Anesthesiologists (ASA) score, and preoperative hemoglobin level were similar between the groups. Univariate, multiple linear regression, and multiple logistic regression analyses were performed. RESULTS: Patients who received topical TXA had significantly greater calculated blood loss compared with those who received IV TXA (mean of 324 compared with 271 mL; p = 0.005). Drain output was significantly higher in the topical TXA group compared with the IV TXA group (mean of 560 compared with 456 mL; p < 0.0001). The rate of transfusion was low in the topical and IV groups, with no significant difference on univariate analysis (1.6% compared with 0.6%, respectively; p = 0.45); however, on multiple logistic regression analysis, patients who received topical TXA were 2.2-fold more likely to receive a transfusion (p < 0.0001). The topical and IV TXA groups did not differ significantly with respect to the rate of thrombotic events (0.6% compared with 1.6%, respectively; p = 0.45). CONCLUSIONS: In this large, randomized clinical trial involving patients undergoing total knee arthroplasty, both IV and topical TXA were associated with a low rate of transfusion. While IV TXA was associated with less calculated blood loss, lower drain output, and fewer transfusions, the small differences between the groups may not be clinically important. Given the low prevalence of thrombotic complications, the relative safety of one formulation of TXA over the other cannot be definitely established. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Abdel MP, Chalmers BP, Taunton MJ, et al. Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty: Both Effective in a Randomized Clinical Trial of 640 Patients. J Bone Joint Surg Am. 2018. PMID: 29916929. doi:10.2106/JBJS.17.00908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。